Alliance Boots posted a double-digit adjusted profit gain of 12.7% to $1.2 billion for its year ended March 31. Almost half of that profit is staked by Walgreens with its 45% share of the European pharmaceutical distributing powerhouse.
A couple days later, Alliance Boots along with Walgreens and AmerisourceBergen announced the necessary regulatory clearances on that strategic partnership, cementing the three companies in place as the largest generic pharmaceutical acquisition company in the world. That deal will further enable the company's to realize greater profit margins.